Triazole compounds with dopamine-D3-receptor affinity

US6583166B1 · kind B1 · utility

Assignee

• Abbott Laboratories · US

Inventors

• Dorothea Starck · Ludwigshafen, DE
• Hans-Jörg Treiber · Münstermaifeld, DE
• Liliane Unger · Ludwigshafen, DE
• Barbara Neumann-Schultz · Ladenburg, DE
• Kai Blumbach · Steinen, DE
• Dietmar Schöbel · Mannheim, DE

Key dates

• Filing date: Jul 16, 2001
• Grant date: Jun 24, 2003
• Expiry date: Jul 16, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to triazole compounds of formula (I), in which R1, R2, A and B have the meanings given in the description. The compounds provided for in the invention have a high affinity for the dopamine-D3-receptor and can therefore be used for the treatment of diseases which respond to the influence of dopamine-D3-ligands.